%0 Journal Article
%T Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study
%A David P. Salmon
%A Douglas R. Galasko
%A Emily C. Edmonds
%A M. Colin Ard
%A Steven D. Edland
%J Archive of "Alzheimer's & Dementia : Translational Research & Clinical Interventions".
%D 2018
%R 10.1016/j.trci.2017.11.001
%X Criteria for mild cognitive impairment (MCI) used in many clinical trials are susceptible to ˇ°false-positive (FP)ˇ± errors that can be avoided by an actuarial psychometric approach
%K Mild cognitive impairment
%K MCI
%K Alzheimer's disease
%K Dementia
%K Donepezil
%K Treatment
%K Neuropsychology
%K Misdiagnosis
%K False positive
%K Cluster analysis
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738722/